济南前列腺增生症济南我龟头不敏感怎么办,济南早谢不治会怎样,济南包皮手术切割多少钱,济南包皮非割不可么,济南哪能治疗早射,济南防止射精办法,济南前列腺在那里[已删除]

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

Tropical Storm #Bertha has formed near the coast of South Carolina this morning. Heavy rainfall will be the biggest threat, along with tropical storm force winds along portions of the South Carolina coast https://t.co/tW4KeFW0gB pic.twitter.com/8CeH3j9TlU— National Hurricane Center (@NHC_Atlantic) May 27, 2020 324

The U.S. Food and Drug Administration has issued a recall for a dietary supplement for men for sexual enhancement.Consumers who have Aphrodisiac Capsules by SD Imports are asked to stop using the drug and return it to the place it was purchased. The FDA says the supplements are tainted with sildenifil. "Sildenafil is an active pharmaceutical ingredient in FDA approved product used in the treatment of erectile dysfunction. The presence of sildenafil in Aphrodisiac capsules renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall," The FDA announcement says.Aphrodisiac capsules are " packaged in a cardboard box with 12 plastic packs in a box. The product can be identified by UPC Code 644118128135. The product was distributed nationwide to retail stores, and a variety of online websites," the FDA says.Consumers may call (248) 850-8523 or email sdimportsllc@gmail.com with concerns or questions. 979

The suspect in the El Paso shooting reportedly admitted to the crime and told detectives that he targeted Mexicans in the shooting, according to the 161

The West Texas man who killed seven people and wounded 25 in a shooting rampage bought his gun in a private sale, which doesn't require a background check, a law enforcement official told CNN.Police have described the firearm Seth Ator, 36, used in Saturday's killing spree in and around Odessa, Texas, as an AR-15-style rifle.Ator tried to buy a firearm on January 14, 2014, but wasn't allowed to, the Texas Department of Public Safety told CNN in an email.The department is prohibited by law from disclosing the reason he was denied the purchase, the DPS said.Ator failed a background check when he applied to get a gun, a representative for the Bureau of Alcohol, Tobacco, Firearms and Explosives said Monday, without giving details.The ATF, the FBI and the DPS are "aggressively following up on" the source that supplied the firearm to Ator, the ATF representative said.Investigators are still searching for a motive in the mass shooting.The man showed up to work Saturday "in a distressed mental state," and was fired, said FBI Special Agent in Charge Christopher Combs.Speaking at a press conference Monday, Combs said the firing wasn't the reason for the shooting spree and that he was "already enraged" when he showed up for work.Ator had been 1264